[Automatic and simultaneous determination of amino acids and guanidines].

PubWeight™: 0.77‹?›

🔗 View Article (PMID 5513166)

Published in Bull Soc Chim Biol (Paris) on January 01, 1970

Authors

J Carles, G Abravanel

Articles citing this

Acetate absorption and metabolism in the rabbit hindgut. Gut (1985) 0.82

Articles by these authors

Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy. Ann Oncol (2007) 1.96

Predictive modelling in hormone-refractory prostate cancer (HRPC). Clin Transl Oncol (2009) 1.40

[Experience with 150 subcutaneous venous reservoirs for venous access and infusion for the treatment of adult patients with oncologic and hematologic disorders and acquired immunodeficiency syndrome]. Med Clin (Barc) (1992) 1.40

Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity. Ann Oncol (2011) 1.34

Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. J Hepatol (2000) 1.21

Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J Pathol (1999) 1.17

Massive tumor implantation in the endoscopic resected area in modified nephroureterectomy. J Urol (1997) 1.08

Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group. J Clin Oncol (2000) 0.99

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma. Ann Oncol (2003) 0.94

Local recurrence of low rectal cancer after abdominoperineal and anterior resection. Br J Surg (1997) 0.93

Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients. Eur J Cancer (1992) 0.92

Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study. Ann Oncol (2010) 0.92

Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg (1996) 0.91

Liver retransplantation for alcoholic cirrhosis recurring within a 21-month period. Transpl Int (1996) 0.89

Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol (1995) 0.87

Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer. Eur J Cancer (2000) 0.85

Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol (1997) 0.84

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study. Br J Cancer (2013) 0.84

Eccrine porocarcinoma presenting with scrotal lymphedema: a case report and review of systemic treatment. Ann Oncol (2010) 0.82

Association of acromegaly and two malignancies: colorectal cancer and non-Hodgkin's lymphoma. Ann Oncol (1994) 0.81

Ectopic liver and hepatocarcinogenesis. Hepatology (1999) 0.81

Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial. Ann Oncol (2012) 0.81

Calcification of lymph node metastases from prostate carcinoma after hormonal treatment: a case report. Prostate (1997) 0.80

Heterozygous protein C deficiency and dysfibrinogenemia acquired by liver transplantation. Transpl Int (1995) 0.80

A dynamic analysis of the ventilatory response to carbon dioxide inhalation in man. J Physiol (1988) 0.79

Bilateral testicular germ cell tumours: a single hospital experience. Clin Transl Oncol (2010) 0.79

Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study. Br J Cancer (2013) 0.79

[Diagnostic and therapeutic strategy in injuries of the kidney. Apropos of a series of 248 cases]. Ann Urol (Paris) (1988) 0.79

Cystic smooth-muscle tumor of the liver and spleen associated with Epstein-Barr virus after renal transplantation. Am J Surg Pathol (1996) 0.79

Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer. Invest New Drugs (1992) 0.78

Case report: incomplete septal cirrhosis with liver cell dysplasia. J Gastroenterol Hepatol (1997) 0.78

[Spontaneous rupture of the esophagus (Boerhaave syndrome) in a patient with scleroderma treated by continuous ambulatory peritoneal dialysis]. Rev Med Interne (1997) 0.78

E400P in advanced seminoma of good prognosis according to the international germ cell cancer collaborative group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experience. Ann Oncol (2001) 0.77

Disseminated Mycobacterium avium infection after liver transplantation. Eur J Clin Microbiol Infect Dis (1998) 0.77

[The automatic determination of organic acids by potentiometry]. Bull Soc Chim Biol (Paris) (1968) 0.77

Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer. Br J Cancer (2002) 0.77

Multiple black hepatocellular adenomas in a male patient. Eur J Gastroenterol Hepatol (2000) 0.76

Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer. Invest New Drugs (1992) 0.76

Do patients with metastatic urothelial carcinoma benefit from docetaxel as second-line chemotherapy? Clin Transl Oncol (2013) 0.76

Cholangiocarcinoma arising in Von Meyenburg complex associated with hepatocellular carcinoma in genetic haemochromatosis. Eur J Gastroenterol Hepatol (2000) 0.76

Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced nonsmall-cell lung cancer: a meta-analytic review. J Surg Oncol (1990) 0.76

Morphology of hepatic stellate cells in patients with fulminant or subfulminant hepatitis requiring liver transplantation. J Submicrosc Cytol Pathol (1996) 0.76

Central venous brachial catheter (P.A.S. Port TM) and catheter scanning system (Cath-Finder TM). J Surg Oncol (1994) 0.75

Pontine myelinolysis following liver transplantation: a report of two cases. Transpl Int (1993) 0.75

[Traumatic dissection of the subrenal aorta. Review of the literature. Apropos of two cases]. J Chir (Paris) (1993) 0.75

[Treatment of intradiverticular pyelocaliceal stones]. Ann Urol (Paris) (1987) 0.75

Therapeutic challenge for Isospora belli enteritis in an AIDS patient who developed Lyell syndrome after co-trimoxazole therapy. Am J Gastroenterol (1989) 0.75

[Reference values of cardiac volume in children and adults of the Ivory Coast]. Poumon Coeur (1977) 0.75

[Castration-resistant prostate cancer: where are we going?]. Actas Urol Esp (2011) 0.75

[Gastric tuberculosis with ulceriform clinical syndrome in 2 patients with a family history of ulcer]. Arch Fr Mal App Dig (1967) 0.75

[Frequency and severity of viral hepatitis C after liver transplantation. Study in 28 patients]. Gastroenterol Clin Biol (1996) 0.75

[Propagation rate of arterial pressure waves as a function of age and physical training]. J Physiol (Paris) (1984) 0.75

[Carcinoma of unknown origin. Diagnostic study of 48 cases and its clinical yield]. Med Clin (Barc) (1989) 0.75

Outcome of liver transplantation in Wilson's disease: A demonstrative case. Parkinsonism Relat Disord (1996) 0.75

Sweet's syndrome and malignancy: a case associated with multiple oral squamous-cell carcinoma. Dermatology (1996) 0.75

Danazol therapy in chronic immune thrombocytopenic purpura. Eur J Haematol (1990) 0.75

Assessment of ventilatory performance of athletes using the maximal expiratory flow-volume curve. Int J Sports Med (1986) 0.75

Drug sensitization: photobinding of sulfanilamide to bovine serum albumin. Photochem Photobiol (1986) 0.75

[Primary isolated vesico-ureteral reflux in children]. Presse Med (1987) 0.75

[Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years]. Ann Chir (1993) 0.75

[Amino acids in the cecum of rabbits]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.75

A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer. Cancer (1990) 0.75

[Tuberculous uretero-hydronephrosis fistulized into an urinoma in a patient with arteritis and an aortic prosthesis]. J Chir (Paris) (1992) 0.75

[Physiological reaction of the plant attacked by a herbicide, simazine]. C R Seances Soc Biol Fil (1966) 0.75

[Organic acids in liver catabolism of amino acids in carp (Cyprinus carpio L.) submitted to prolonged fasting]. C R Seances Soc Biol Fil (1972) 0.75

[Splenoganglionic amylosis and hydatid cyst of the liver. Antomoclinical case]. J Med Bord (1967) 0.75

[Amino acids and carboxylic acids in the cecum of the rabbit]. Ann Biol Anim Biochim Biophys (1973) 0.75

Skin, hair and nail changes in a case of citrullinemia with late manifestation. Dermatologica (1984) 0.75

Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Study of the incidence of delayed emesis. Oncology (1991) 0.75

Anal carcinoma: a 14 year experience. Rev Esp Enferm Dig (1997) 0.75

A phase II study of days 1 and 8 cisplatin and recombinant alpha-2B interferon in advanced non-small cell lung cancer. Cancer (1991) 0.75

[The description of a new cellular type, Pinocchio cells, induced during the treatment of solid tumors with interleukin-2]. Med Clin (Barc) (1990) 0.75

[Absorption of carboxylic acids in the cecal wall of the rabbit]. Ann Biol Anim Biochim Biophys (1973) 0.75

[Cockett's syndrome caused by an ectopic kidney. Apropos of two cases]. J Chir (Paris) (1992) 0.75

[Some improvements for column chromatography of organic acids]. Bull Soc Chim Biol (Paris) (1965) 0.75

Sequential combination of methotrexate (MTX), 5-fluorouracil (FU), and high-dose folinic acid (FA) in advanced colorectal cancer: double biochemical modulation? Am J Clin Oncol (1991) 0.75

[Analytical characterization of varietal wines and aging phenomena]. Ann Nutr Aliment (1978) 0.75

[Bladder replacement with colon segments]. Ann Urol (Paris) (1988) 0.75

[Recomendations on the management of controversies in advanced castrate-resistant prostate cancer]. Actas Urol Esp (2012) 0.75

[Acute necrotizing enterocolitis in adults. Analysis of a homogeneous series of 12 cases. Review of the literature]. J Chir (Paris) (1992) 0.75

Sweet's syndrome and acute myelogenous leukemia. Int J Dermatol (1990) 0.75

[Gastric duplication or pancreatic pseudocyst. Diagnostic difficulties apropos of a case]. Gastroenterol Clin Biol (1996) 0.75

5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors. Ann Oncol (1991) 0.75

[Compressive thigh hematoma. Apropos of a case of fissured superficial femoral aneurysm in megadolicho-arteries. Review of the literature]. J Chir (Paris) (1991) 0.75

[Not Available]. Etudes (Paris) (1983) 0.75

Acute aortic dissection during sorafenib-containing therapy. Ann Oncol (2009) 0.75

[Atypical localization of synovial sarcoma]. Med Clin (Barc) (1993) 0.75

[Some effects of indium poisoning on metabolism of urea]. C R Seances Soc Biol Fil (1969) 0.75